Addressing the editor of The Lancet, the scientists said they saw patterns in the data that looked 'highly unlikely'.The letter, published on the personal blog page of one of the signatories, said the Phase I/II trial results data showed multiple participants reporting identical antibody levels
from mint - News https://ift.tt/3ifD2SD
https://ift.tt/eA8V8J
from mint - News https://ift.tt/3ifD2SD
https://ift.tt/eA8V8J
Post a Comment